## **Core Concept**
The question revolves around the diagnosis of a condition characterized by recurrent abortions and venous thrombosis. This clinical presentation suggests an underlying **thrombophilic disorder**, which is a condition that predisposes individuals to form blood clots.

## **Why the Correct Answer is Right**
The correct answer, **Antiphospholipid Syndrome (APS)**, is a type of thrombophilic disorder that is strongly associated with recurrent venous or arterial thrombosis and recurrent miscarriages. APS is an autoimmune condition where the body produces **antiphospholipid antibodies**, which are directed against phospholipid-binding proteins. These antibodies can lead to a prothrombotic state by several mechanisms, including the activation of endothelial cells, the inhibition of anticoagulant pathways, and the enhancement of platelet activation and aggregation.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While **Protein C deficiency** is a cause of thrombophilia, it typically presents with a family history of thrombosis and does not directly explain the recurrent abortions.
- **Option B:** **Protein S deficiency** is another cause of thrombophilia but, like Protein C deficiency, it is more commonly associated with a familial history of thrombosis rather than recurrent miscarriages.
- **Option C:** **Factor V Leiden mutation** is a common cause of thrombophilia, especially in individuals of European descent. However, similar to Protein C and S deficiencies, it doesn't directly explain the history of recurrent abortions.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **Antiphospholipid Syndrome** is a critical diagnosis to consider in patients with recurrent venous or arterial thrombosis and recurrent miscarriages. The diagnosis requires the presence of **antiphospholipid antibodies** (lupus anticoagulant, anticardiolipin antibodies, or anti-β2 glycoprotein I antibodies) along with clinical criteria (vascular thrombosis or pregnancy morbidity).

## **Correct Answer:** D. Antiphospholipid Syndrome.